FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293281518> ?p ?o ?g. }

• W4293281518 endingPage "137" @default.
• W4293281518 startingPage "131" @default.
• W4293281518 abstract "Free AccessCPAPFrequency of Sleep Apnea in Stroke and TIA Patients: A Meta-analysis Karin G. Johnson, M.D., Douglas C. Johnson, M.D. Karin G. Johnson, M.D. Address correspondence to: Karin G. Johnson, M.D., Department of Neurology, Baystate Medical Center, 3300 Main St Suite 3C, Springfield, MA 01199413-794-7033413-794-7297 E-mail Address: [email protected] Baystate Medical Center, Springfield, MA Search for more papers by this author , Douglas C. Johnson, M.D. Massachusetts General Hospital, Boston, MA Search for more papers by this author Published Online:April 15, 2010https://doi.org/10.5664/jcsm.27760Cited by:319SectionsAbstractPDF ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutABSTRACTStudy Objectives:To determine the frequency of sleep disordered breathing (SDB) in ischemic and hemorrhagic stroke and transient ischemic attack (TIA) patients by meta-analysis.Methods:A systematic literature search using Medline, EMBASE and CINAHL and a manual review of references through December 2008 was conducted using specific search terms. The frequency of SDB stratified by apnea hypopnea index (AHI) was extracted by the author. Weighted averages using a random-effects model are reported with 95% confidence intervals.Results:Twenty-nine articles evaluating patients with auto-CPAP, limited-channel sleep study, or full polysomnography were included in this study. In meta-analysis of 2,343 ischemic or hemorrhagic stroke and TIA patients, the frequency of SDB with AHI > 5 was 72% and with AHI > 20 was 38%. Only 7% of the SDB was primarily central apnea. There was no significant difference in SDB prevalence by event type, timing after stroke, or type of monitoring. Males had a higher percentage of SDB (AHI > 10) than females (65% compared to 48% p = 0.001). Patients with recurrent strokes had a higher percentage of SDB (AHI > 10) than initial strokes (74% compared to 57% p = 0.013). Patients with unknown etiology of stroke had a higher and cardioembolic etiology a lower percentage of SDB than other etiologies.Conclusions:SDB is very common in stroke patients irrespective of type of stroke or timing after stroke and is typically obstructive in nature. Since clinical history alone does not identify many patients with SDB, sleep studies should be considered in all stroke and TIA patients.Citation:Johnson KG; Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 2010;6(2):131-137.INTRODUCTIONIn the US, approximately 795,000 people have strokes and 135,000 people die from stroke complications each year, making it the third most common cause of death. There are an estimated 5.6 million stroke survivors receiving acute and long-term care costing $68.9 billion per year.1 Aggressive treatment of risk factors in stroke patients, including hypertension, atrial fibrillation, and carotid stenosis, is widely accepted. Obstructive sleep apnea (OSA) has been shown to increase the risk of these and other stroke risk factors.2 Evaluation for OSA is not routinely recommended as part of a stroke workup3 despite growing evidence that OSA is an independent risk factor for stroke, that treating OSA improves recovery from stroke, and that treating severe OSA decreases cardiovascular morbidity and mortality.2BRIEF SUMMARYCurrent Knowledge/Study Rationale: Studies of the prevalence of sleep disordered breathing (SDB) in stroke and transient ischemic attack (TIA) patients use varying methods and have wide variations ranging form 30-80%. There is growing evidence that obstructive sleep apnea affects stroke morbidity and mortality, so a more precise estimate of this stroke risk factor is important.Study Impact: This study provides a meta-analysis of such studies, finding that obstructive sleep apnea is very common among patients with TIA and stroke, and is more common among patients with strokes of unknown origin and those with recurrent strokes. The findings of this study support screening for SDB in all stroke and TIA patients.The community prevalence of sleep disordered breathing (SDB) has been reported to range from 8% to 57% in men and 9% to 35% in women (30-70 years) and between 12% to 81% in the elderly (65–100 years).4 In studies of frequency of OSA in stroke patients, there similarly has been a wide variability in the reported frequencies of OSA ranging from about 30% to 80%.5 Approximately 30% of stroke patients with severe OSA would be missed if clinical history alone were used to screen for OSA.6 There are currently no guidelines about whether stroke patients should be routinely evaluated for the presence of OSA or how they should be evaluated.3 The aim of this study is to provide an estimate of the frequency of OSA in stroke patients, and to determine what factors may influence its frequency. A meta-analysis of studies of patients with acute strokes or TIAs who were tested for OSA with sleep studies was performed to generate this information.RESEARCH DESIGN AND METHODSData ExtractionA Medline, EMBASE, and CINAHL search was performed through December 2008 using the terms apnea, obstructive, sleep, TIA, and stroke. Further articles were found by reviewing bibliographies of these studies. Non-English language articles and abstracts were excluded. If there was a question of duplicative data, authors were contacted to determine whether there was overlap of patients. Studies were excluded if oximetry alone or snoring history was used to define SDB instead of sleep studies. The first author performed the searches and reviewed the initial citations. The second author reviewed all studies that involved testing for sleep apnea in stroke patients to confirm the exclusions and review the methodology.The percentage of patients with sleep disordered breathing determined by AHI criteria of > 5, > 10, > 20, > 30, and > 40, as well as the percentage of patients with primarily central apnea was determined. The studies were analyzed for age, BMI, gender differences, differences between TIA, ischemic stroke and hemorrhagic stroke patients, initial stroke compared to recurrent stroke events, time from stroke onset to testing, inpatient compared to rehab setting, effect of stroke localization, and presenting symptoms. When appropriate, average characteristics of studies were reported as mean ± standard deviation.The studies were analyzed for sleep study type including full polysomnography (PSG) with EEG, limited-channel without EEG or auto-CPAP in diagnostic mode. The method of testing included thermistor, pressure transducer, effort band, or auto-CPAP device. Most studies defined apnea as > 10 sec of no airflow, with 2 studies also using > 10 sec of no airflow associated with a 4% oxygen desaturation. Hypopnea was variably defined with most studies using a 50% decrease in airflow and/or effort either alone or 30% to 50% decrease with arousal and/or 3% or 4% oxygen desaturation. AHI is the number of apneas and hypopneas per hour of sleep for full PSG and per hour of study duration for limited-channel studies in which sleep stage was not determined.Statistical AnalysisComposite estimates of the percentage of patients with SDB (effect size) were computed for all studies combined, and separately for studies grouped according to several criteria. The criteria included event type, first or recurrent event, sex, study location, study timing, stroke etiology, study type, testing method, and hypopnea criteria. The Q-test was used to test for significant heterogeneity of percentage of patients with SDB according to AHI cut-off points among studies. In the presence of significant heterogeneity of variance among groups, a random effects model was used.7 It gives a more conservative estimate of the variability in treatment effect (larger standard error and wider 95% confidence intervals) than the fixed effects method. A funnel plot was done to evaluate for possible publication bias.All analyses were conducted using Comprehensive Meta-Analysis software.8 Analyses were performed to determine if there were differences among subgroups of studies according to various criteria. A random effects model was used to combine studies within each subgroup. A variant of the Q-statistic was used to assess the difference in percentage of patients with AHI > 10 between subgroups of studies. The study-to-study variance (tau-squared) was not assumed to be the same for all subgroups—this value was computed within subgroups and not pooled across subgroups. Composite estimates of percentage of patients with AHI > 10 and heterogeneity statistics were derived for each subgroup. Meta-regression using a random effects model was used to test whether age or BMI correlated with the proportion of patients with AHI > 10. Chi square with Yate's correction was used to compare groups.RESULTSThe initial search identified 1,239 possible papers. Fifty-two articles reported prevalence of SDB in stroke or TIA patients. Exclusions included eleven studies with duplicative data, 2 non-English language studies, 3 studies testing with oximetry, 5 studies defining OSA by snoring, one abstract, and one study which did not report AHI cut-offs. Twenty-nine studies including 2,343 patients evaluating patients with full PSG with EEG (n = 11), limited channel sleep study (n = 13), or auto-CPAP in diagnostic mode (n = 5) were included.4–6,9–35 A funnel plot (data not shown) did not suggest publication bias.Table 1 summarizes the study characteristics. Twenty studies evaluated patients who were admitted to an acute stroke unit, 7 evaluated patients admitted to rehabilitation units, one to either, and one study evaluated a stroke cohort. The timing of sleep study after stroke onset was within one week in 16 studies, 7-28 days in 8 studies (some patients in this group were studied within a week), and over 28 days in 5 studies, including one study approximately 3 years after stroke onset. A total of 2,151 patients had ischemic strokes, 104 had TIAs, and 87 had hemorrhagic strokes. Of the 26 studies reporting the percentage of females studied, on average 35.4% ± 11.3% (range 14% to 58%) were female. The average age was 65 ± 6 years and average BMI was 26.4 ± 1.7 kg/m2. Using a linear meta-regression, there was a trend toward increasing frequency of AHI > 10 with increasing average age (p = 0.056). Average BMI had no effect (p = 0.14).Table 1 Study characteristicsStudy & Year, CountryN (% female)Stroke Type (% recurrent)% of EligibleLocationStudy Type/ Test methodHypopnea CriteriaTime After CVAAge yBMI kg/ m2Bassetti 1999, USA80 (38)I, T (11)63%Stroke UnitF/ThermistorArousal9 d6029 Bassetti 2006, Switzerland152 (32)I (-)-Stroke UnitA/PressureFlow3 ± 2 d5626 Broadley 2007, Australia55 (42)I, H (-)68%Stroke UnitL/ PressureFlow2 d7127 Brown 2008, USA30 (33)I (27)-Stroke – RehabF/ PressureArousal< 7 d67- Cadhilac 2005, Australia78 (32)I, H (19)29%HomeL/ PressureFlow3 y6428 Disler 2002, Australia38 (-)I, H (-)-Rehab UnitA/ PressureFlow7-28 d65- Dyken 1996, USA24 (46)I, H (-)56%Stroke UnitF/ PressureDesaturation14-35 d6528 Dziewas 2005, Germany102 (33)I (25)-Stroke UnitL/ ThermistorEffort< 3 d6526 Dziewas 2007, Germany214 (34)I (0)-Stroke UnitL/ ThermistorEffort< 3 d6626 Dziewas 2008, Germany55 (24)I (0)-Stroke UnitL/ ThermistorEffort< 3 d6526 Harbison 2003, UK78 (49)I, H (18)-Stroke UnitA/ PressureFlow7-14 d73- Hermann 2007, Switzerland31 (36)I (0)-Stroke UnitF/ ThermistorArousal5 d50- Hsu 2006, UK66 (32)I, H (9)10%Stroke UnitL/ PressureFlow-5014-19 d7226 Hui 2002, China51 (45)I (-)80%Stroke UnitF/ PressureArousal3 d6424 Iranzo 2002, Spain50 (40)I (0)-Stroke UnitF/ ThermistorArousal-E1 d6726 Kaneko 2003, Canada60 (39)I, H (18)98%Rehab UnitF/ Effort BandEffort44 ± 3 d6628 Martinez 2005, Spain95 (-)I, T (-)68%Rehab UnitA/ PressureFlow64 ± 11 d7327 Mohsenin 1995, USA10 (20)I (-)59%Rehab UnitF/ ThermistorDesaturation< 1 y5626 Nachtmann 2003, Germany235 (30)I (25)59%Rehab UnitF/ ThermistorArousal27 d66- NorAdina 2006, Malaysia28 (29)I (11)31%Stroke UnitA/ PressureFlow7-28 d6023 Palombini 2006, USA21 (-)I (-)42%Stroke UnitF/ PressureDesaturation< 30 d6223 Parra 2000, Spain161 (49)I, T, H (0)-Stroke UnitL/ ThermistorDesaturation2-3 d7227 Rola 2007, Poland70 (14)I, T (-)-Stroke UnitL/ PressureFlow-50< 7 d6628 Sandberg 2001, Sweden133 (59)I, H (39)88%Rehab UnitL/ ThermistorDes-body-pulse23 d7724 Selic 2005, Switzerland41 (20)I (-)91%Stroke UnitL/ PressureFlow-501 d6327 Siccolli 2008, Switzerland74 (34)I (0)-Stroke UnitL/ PressureFlow-50< 3 d6328 Turkington 2002, UK120 (58)I (27)82%Stroke UnitL/ ThermistorDesaturation1 d7924 Wessendorf 2000, Germany147 (35)I (0)86%Rehab UnitF/ ThermistorArousal46 ± 20 d6128 Wierzbicka 2006, Poland43 (19)I, T (-)-Stroke UnitL/ PressureDesaturation< 7 d6928 - refers to results not available. Stroke type: H, Hemorrhagic; I, Ischemic; T, Transient ischemic attack. Study Type: F, Full PSG (including EEG); L, Limited (without EEG); A, Auto-CPAP diagnostic mode. Test method: Pressure, nasal pressure transducer. Hypopnea Criteria: Arousal, flow reduction with arousal or oxygen desaturation (of at least 3-4%); Arousal-E, thoracic/abdominal reduction with arousal or desaturation; Desaturation, flow reduction with desaturation; Des-body-pulse, flow reduction with desaturation, body movement or pulse change; Effort, effort band reduction or thoracic/abdominal reduction alone; Flow, flow reduction alone; Flow-50, flow reduction at least 50% or flow reduction at least 30% with desaturation or arousal (if full PSG). Time: d, day; y, year.In most studies, patients were excluded if there was a serious medical condition, dementia or confusion, or if consent could not be obtained. Eight studies excluded patients with known OSA12,22,24,26,29 or prior CPAP use.9,11,23 Of the 17 studies which listed how many patients were excluded, the average inclusion rate was 64% ± 26% (range 10% to 100%).Table 2 summaries the frequency of SDB in each individual study. Figure 1 shows a forest plot (mean with 95% confidence intervals) of all studies showing the proportion of patients with an AHI > 10. There was significant heterogeneity among studies (Q = 94.38, df = 22, p < 0.001), validating the choice of a random effects model for the meta-analysis. Table 3 summarizes the frequency of SDB after stroke or TIA according to different AHI cut-off points. The frequency of SDB in stroke and TIA patients ranged from 72% (95% CI 60–81) for AHI > 5 to 14% (95% CI 7–25) for AHI > 40. Seventeen of the studies reported the percentage of patients with primarily central apneas or Cheyne Stokes respiration (7% [95% CI 4.5–12.0]).Table 2 Percentage of patients with SDB by AHI cut-off pointsStudy – Year > 5 > 10 > 20 > 30 > 40 Bassetti 199963Bassetti 2006583117Broadley 200758Brown 200873Cadhilac 20058145188Disler 200261Dziewas 200552Dziewas 200751Dziewas 200878Dyken 19968371464229 Harbison 2003926746Herman 200758Hsu 200650Hui 2002674931Iranzo 20026246Kaneko 200372Martinez 200554Mohsenin 1995Nachtmann 20034325NorAdina 2006937939Palombini 200676Parra 200072472811 Rola 200766Sandberg 2001775537218 Selic 20056929Siccolli 200855Turkington 2002806130Wessendorf 2000614322Wierzbicka 2006634021Figure 1 Forest plot of percentage of patients with AHI > 10 with 95% confidence intervals.Download FigureTable 3 Percentage of stroke or TIA patients with SDB stratified by AHICutpoint# Studies (# patients)% (95% CI) AHI > 59 (908)72 (60–81) AHI > 1024 (1980)63 (58–68) AHI > 2015 (1405)38 (31–46) AHI > 3010 (865)29 (21–37) AHI > 403 (318)14 (7–25) Central*17 (1286)7 (5–12) *Percentage of patients who had primarily central apneaTable 4 shows the results of the group comparisons according to nine dimensions: event type, first or recurrent stroke, sex, patient location, timing of sleep study after stroke, stroke etiology, sleep study type, testing method, and hypopnea criteria. There were significant differences in percentage of patients with AHI > 10 in 4 dimensions: initial or recurrent stroke, sex, patient location, and stroke etiology. The percentage of patients with AHI > 10 was higher in patients with recurrent stroke (73%) than first stroke (57%) (p = 0.013). More males than females had AHI > 10 (65% vs 48% p = 0.001). The percentage of patients with AHI > 10 was higher in the studies of stroke units (64%) and rehabilitation units (57%) than the one stroke cohort (45%) (p = 0.009).Table 4 Percentage of patients with AHI > 10 by subgroupsDimensionGroup# Studies% AHI > 10 (95% CI)p-value OverallAll Studies2362 (57–67)Event typeIschemic Stroke361 (42–78)0.489 TIA352 (30–73)Hemorrhagic Stroke471 (50–85)Prior eventFirst957 (49–64)0.013 Recurrent374( 63–82)SexFemale1248 (40–56)0.001 Male1265 (59–71)Patient locationCohort145 (34–56)0.009 Rehab Unit457 (45–68)Inpatient Unit1864 (58–69)Timing of study after CVA< 7 days1360 (55–65)0.128 7-28 days772 (60–81)> 28 days353(37–69)Stroke etiologyCardioembolic348 (41–56)0.005 Macrovascular371 (49–86)Microvascular361 (46–74)Other366 (31–90)Unknown382 (66–91)Study typeFull PSG (with EEG)863 (54–71)0.226 Limited (without EEG)1158 (51–64)AutoCPAP475 (54–88)Testing methodPressure Transducer858 (50–66)0.319 Thermistor1059 (53–66)Auto-CPAP475 (54–88)Hypopnea criteriaArousal or desat with reduced flow558 (48–68)0.860 Desaturation with reduced flow563 (51–75)Effort reduction463 (50–74)Flow reduction alone667 (52–79)Flow-50260 (49–70)CI, confidence interval. The p-values indicate whether any of the subgroups had a statistical effect on the percentage of patients with AHI > 10 determined with a random effects model.Hypopnea criteria: Flow-50, flow reduction at least 50% or flow reduction at least 30% with desaturation or arousal (if full PSG).There were limited data available to assess whether the frequency of SDB was affected by stroke etiology or stroke location. Three studies reported the frequency of SDB according to stroke etiology including macrovascular, microvascular, cardioembolic, unknown, and other.9,13,14 There was a significantly higher percentage of patients with AHI > 10 if the cause was unknown (82%) and lower percentage (48%) if the cause was cardioembolic (p = 0.005)The type of stroke event did not affect the percentage of patients with an AHI > 10. Only 3 of the 5 studies including TIA patients6,28,29 and 4 of 9 studies including patients with hemorrhagic stroke patients10,22,28,30 reported the proportion of patients with AHI > 10. There was no difference in AHI frequency among event types: 71% of hemorrhagic stroke patients, 61% of ischemic stroke patients, and 52% of TIA patients had AHI > 10 (p = 0.548).Only 3 studies reported the frequency of SBD differentiating brainstem and hemispheric location.16,22,28 There was no difference in percentage of patients with AHI > 10 in the 23 patients with brainstem strokes (83%) compared to the 109 patients with hemispheric strokes (73%) (p = 0.449). Five additional studies also found no difference in SDB frequency when stroke location was evaluated but did not report the data.20,21,30,33,35The prevalence of snoring in stroke patients was reported by 6 studies.6,9,21,23,26,34 Fifty-three percent of 231 patients without SDB snored, while 73% of 371 patients with SDB had a history of snoring (p < 0.001). The relative risk of snoring in SDB patients was 1.39.DISCUSSIONThis meta-analysis found that SDB is present in up to 72% of ischemic and hemorrhagic stroke and TIA patients. The SDB was primarily obstructive in nature, with only 7% of patients having primarily central apneas. SDB was more common in male patients, those with recurrent strokes and those with strokes of unknown etiology. SDB was less common among those with strokes of cardioembolic etiology. Other factors, including stroke event type, patient location, timing, and testing methods after stroke, did not affect the percentage of patients with OSA.The SDB frequency was high in stroke patients despite a relatively low average BMI of 26.4 kg/m2. The frequency of OSA found in this study was very similar to rates found in a community-based study of adults with age greater than 65 (62% with AHI > 10)36; however, it was significantly higher than the rates of OSA found in younger adults.4 This meta-analysis found a trend toward increasing average age in the study population being associated with increasing rates of SDB. Several of the individual studies reported a significant relationship between increasing age and OSA frequency.9,13,14,15,35 There are no studies of the frequency of OSA in stroke patients broken down by age groups. However, it is likely that younger stroke patients would have a higher OSA frequency than a similar aged non-stroke population.This analysis found no significant difference between the different stroke types, although there was limited data on hemorrhagic stroke and TIA patients. There was no difference in OSA frequency with the timing of the sleep study after stroke onset. In 2 studies that found a decrease in SDB with time, there was either a decrease in central apneas28 or there was improvement in OSA only in patients with dysphagia.37 One factor that may increase the frequency of OSA in acute stroke patients is the increase in supine positioning.11,15 Because the stability of OSA after stroke and the similar rates in TIA and stroke patients, it has been previously proposed that OSA precedes stroke onset.28 Another argument that OSA precedes stroke onset is that brainstem and hemispheric strokes have no differences in rates of OSA.In this meta-analysis, unknown cause for stroke was associated with higher frequencies of SDB and cardioembolic cause a lower frequency of SDB. In other studies which did not provide data, but commented on whether stroke etiology was a factor, most reported no relationship between etiology and the frequency of SDB. Given that OSA has multiple mechanisms2 by which it can increase stroke risk including causing endothelial damage, increasing hypertension, increasing right to left shunting through patent foramen ovale,38 increasing hypercoagulability, and increasing cardiac arrhythmias, it is not surprising that there is no difference in frequency in patients with microvascular, macrovascular, or other causes of stroke. That patients with an unknown cause of stroke had increased rate of SDB suggests that OSA may be the cause in some of these patients. That patients with a cardioembolic cause of stroke had a lower rate of SDB suggests that many of the emboli were not related to OSA, but to other factors such as atrial fibrillation.The variability in the rates of SBD in the studies may be related to several factors including whether the patients were in inpatient or rehabilitation settings, exclusion criteria, testing method, scoring method, type of stroke, sex, age, and BMI. However only male sex and recurrent strokes were associated with statistically higher frequencies of SDB. The studies were done in 12 different countries, which may be another factor. One study with higher rates of SDB may be related to the use of auto-CPAP and an older mean age.17 However in the subanalyses, the use of auto-CPAP for diagnosis and age did not affect SDB frequency.While there was no evidence of publication bias affecting the overall percentages, some of the subanalyses are likely affected. For example, there was a difference in the 3 studies that reported the frequency of SDB in patients with first compared to recurrent stroke, while 2 studies that did not report data commented that there was no significant difference found.22,33The reported frequencies likely underestimate the actual prevalence of SDB in stroke patients. Most of the studies included patients consecutively admitted to stroke or rehabilitation units, but excluded patients if they had severe medical conditions, died prior to sleep study, or were unable to consent. Eight studies excluded patients with known OSA. One study with lower rates of SDB used a stroke cohort 3 years after stroke onset and only included 29% of the original cohort.4 It is possible that increased morbidity and mortality caused by SDB in stroke patients caused fewer of these patients to be included.While some symptoms such as snoring, daytime sleepiness and witnessed apneas may increase the likelihood of the patient having OSA, a significant number of patients will be missed if history alone is used for screening. In this meta-analysis, over 25% of patients with SDB did not snore while over 50% of patients without SDB did snore. Bassetti et al. found that only 70% patients with AHI > 30 and 32% of patients with AHI 10–30 had clinically probable OSA.6While large randomized trials of the effects of OSA on stroke morbidity and mortality are not available, there is a growing body of literature. OSA has been shown to increase the risk of stroke and multiple stroke risk factors including hypertension and atrial fibrillation.2 Morbidity after stroke is worsened with more depression, delirium and ADL dependence30 and lower functional capacity and longer hospitalization.22 In a 10-year follow-up of stroke patients, there was a higher risk of death in patients with OSA (adjusted hazard ratio 1.76).39Several studies have evaluated the use of CPAP in stroke patients with OSA. One randomized trial did not find any functional improvement after stroke, but it was limited by poor CPAP compliance.19 Another study found a benefit of CPAP in reducing cardiovascular events after stroke.23 A third study found treatment with CPAP in stroke patients with AHI > 20 reduced 5-year mortality from stroke and all cardiovascular and noncardiovascular causes compared to the 70% of patients intolerant to CPAP. 40 Similar benefit was found in preventing cardiovascular events in primary prevention.41More studies are needed to clarify the relationship between OSA and stroke and TIA patients. There have been no studies specifically studying the frequency of OSA in younger stroke patients, especially with unknown causes of stroke, to see if there is a higher prevalence of OSA that might explain the stroke etiology. Further randomized trials of CPAP in acute stroke patients are needed to clarify the benefits on recovery from the initial event. Studies in both mild-moderate as well as severe sleep apnea are needed. CPAP trials in TIA patients are needed to assess the benefits in secondary prevention. The challenge of these studies will be to determine the optimal methods of diagnosing OSA and quickly treating patients since the risk of stroke is the highest in the first 30 days.This meta-analysis found that obstructive sleep apnea is very common in patients with TIA and stroke, is more common in patients with recurrent stokes and those with strokes of unknown etiology, and is less common in patients with strokes of cardioembolic etiology. Multiple testing methods including full polysomnography with EEG, limited-channel devices and auto-CPAP devices can be used to diagnose sleep apnea in stroke patients. Given the high frequency of OSA in stroke patients, the effects of OSA on stroke morbidity and mortality, and the improvements with CPAP therapy, screening for OSA in all stroke and TIA patients may be warranted.DISCLOSURE STATEMENTThis was not an industry supported study. The authors have indicated no financial conflicts of interest.REFERENCES1 Lloyd-Jones DAdams RCarnethon M, et al.Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation2009119e21181, 19075105Google Scholar2 Bradley TDFloras JSObstructive sleep apnea and its cardiovascular consequencesLancet20093738293, 19101028CrossrefGoogle Scholar3 Summers DLeonard AWentworth D, et al.Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient. A scientific statement from the American Heart AssociationStroke200940291144, 19478222CrossrefGoogle Scholar4 Cadilhac DAThorpe RDPearce DC, et al.Sleep disordered breathing in chronic stroke survivors. A study of the long term follow-up of the SCOPES cohort using home based polysomnographyJ Clin Neurosci20051263237, 16115548CrossrefGoogle Scholar5 Hui DSChoy DKWong LK, et al.Prevalence of sleep-disordered breathing and continuous positive airway pressure compliance: results in Chinese patients with first-ever ischemic strokeChest200212285260, 12226023CrossrefGoogle Scholar6 Bassetti CAldrich MSSleep apnea in acute cerebrovascular diseases: final report on 128 patientsSleep19992221723, 10201066CrossrefGoogle Scholar7 DerSimonian RLaird NMeta-analysis in clinical trails. Control Clin Trials1986717788Google Scholar8 Borenstein MHedges L, et al.Comprehensive meta-analysis2005Englewood NJBiostatGoogle Scholar9 Bassetti CLMilanova MGugger MSleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcomeStroke20063796772, 16543515CrossrefGoogle Scholar10 Broadley SAJorgensen LCheek A, et al.Early investigation and treatment of obstructive sleep apnoea after acute strokeJ Clin Neurosci20071432833, 16790349CrossrefGoogle Scholar11 Brown DLisabeth LZupancic M, et al.High prevalence of supine sleep in ischemic stroke patientsStroke20083925114, 18617656CrossrefGoogle Scholar12 Disler PHansford AWright P, et al.Diagnosis and treatment of obstructive sleep apnea in a stroke rehabilitation unit: A feasibility studyAm J Phys Med Rehab2002816225CrossrefGoogle Scholar13 Dziewas RHumpert MHomann B, et al.Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victimsJ Neurol200525213948, 16021359CrossrefGoogle Scholar14 Dziewas RRitter MUsta N, et al.Atherosclerosis and obstructive sleep apnea in patients with ischemic strokeCerebrovasc Dis2007241226, 17565197CrossrefGoogle Scholar15 Dziewas RHopmann BHumpert M, et al.Positional sleep apnea in patients with" @default.
• W4293281518 created "2022-08-27" @default.
• W4293281518 creator A5005530692 @default.
• W4293281518 creator A5046281043 @default.
• W4293281518 date "2010-04-15" @default.
• W4293281518 modified "2023-10-02" @default.
• W4293281518 title "Frequency of Sleep Apnea in Stroke and TIA Patients: A Meta-analysis" @default.
• W4293281518 doi "https://doi.org/10.5664/jcsm.27760" @default.
• W4293281518 hasPublicationYear "2010" @default.
• W4293281518 type Work @default.
• W4293281518 citedByCount "292" @default.
• W4293281518 countsByYear W42932815182012 @default.
• W4293281518 countsByYear W42932815182013 @default.
• W4293281518 countsByYear W42932815182014 @default.
• W4293281518 countsByYear W42932815182015 @default.
• W4293281518 countsByYear W42932815182016 @default.
• W4293281518 countsByYear W42932815182017 @default.
• W4293281518 countsByYear W42932815182018 @default.
• W4293281518 countsByYear W42932815182019 @default.
• W4293281518 countsByYear W42932815182020 @default.
• W4293281518 countsByYear W42932815182021 @default.
• W4293281518 countsByYear W42932815182022 @default.
• W4293281518 countsByYear W42932815182023 @default.
• W4293281518 crossrefType "journal-article" @default.
• W4293281518 hasAuthorship W4293281518A5005530692 @default.
• W4293281518 hasAuthorship W4293281518A5046281043 @default.
• W4293281518 hasBestOaLocation W42932815181 @default.
• W4293281518 hasConcept C111919701 @default.
• W4293281518 hasConcept C126322002 @default.
• W4293281518 hasConcept C127413603 @default.
• W4293281518 hasConcept C164705383 @default.
• W4293281518 hasConcept C2775841894 @default.
• W4293281518 hasConcept C2776006263 @default.
• W4293281518 hasConcept C2777935920 @default.
• W4293281518 hasConcept C2778205975 @default.
• W4293281518 hasConcept C2780645631 @default.
• W4293281518 hasConcept C2781326671 @default.
• W4293281518 hasConcept C41008148 @default.
• W4293281518 hasConcept C71924100 @default.
• W4293281518 hasConcept C78519656 @default.
• W4293281518 hasConcept C95190672 @default.
• W4293281518 hasConceptScore W4293281518C111919701 @default.
• W4293281518 hasConceptScore W4293281518C126322002 @default.
• W4293281518 hasConceptScore W4293281518C127413603 @default.
• W4293281518 hasConceptScore W4293281518C164705383 @default.
• W4293281518 hasConceptScore W4293281518C2775841894 @default.
• W4293281518 hasConceptScore W4293281518C2776006263 @default.
• W4293281518 hasConceptScore W4293281518C2777935920 @default.
• W4293281518 hasConceptScore W4293281518C2778205975 @default.
• W4293281518 hasConceptScore W4293281518C2780645631 @default.
• W4293281518 hasConceptScore W4293281518C2781326671 @default.
• W4293281518 hasConceptScore W4293281518C41008148 @default.
• W4293281518 hasConceptScore W4293281518C71924100 @default.
• W4293281518 hasConceptScore W4293281518C78519656 @default.
• W4293281518 hasConceptScore W4293281518C95190672 @default.
• W4293281518 hasIssue "02" @default.
• W4293281518 hasLocation W42932815181 @default.
• W4293281518 hasOpenAccess W4293281518 @default.
• W4293281518 hasPrimaryLocation W42932815181 @default.
• W4293281518 hasRelatedWork W1969950653 @default.
• W4293281518 hasRelatedWork W2001192257 @default.
• W4293281518 hasRelatedWork W2016370421 @default.
• W4293281518 hasRelatedWork W2058760891 @default.
• W4293281518 hasRelatedWork W2115730526 @default.
• W4293281518 hasRelatedWork W2319103027 @default.
• W4293281518 hasRelatedWork W2763022105 @default.
• W4293281518 hasRelatedWork W3032263340 @default.
• W4293281518 hasRelatedWork W3092127899 @default.
• W4293281518 hasRelatedWork W93347451 @default.
• W4293281518 hasVolume "06" @default.
• W4293281518 isParatext "false" @default.
• W4293281518 isRetracted "false" @default.
• W4293281518 workType "article" @default.